Jabez Biosciences, Inc.

CRANBERRY TWP., PA · Founded 2024 · CIK 0002038185 · Biotech · Private

Oral small-molecule cancer therapeutic (DHODH inhibitor) designed for synergy with standard cancer treatments

jabezbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.9M
3 Form D · Mar 2026
7 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 2 same dayForm D · SEC$2,550,000
Private capital raised· 2 of 2 same dayForm D · SEC$1,326,500
Private capital raisedForm D · SEC$31,200
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1522SHY THERAPEUTICS, LLC——
1523Varda Space——
1524Phenzyme, Inc.——
1525Jabez Biosciences, Inc.—$3.9M
1526DRAGONASE LLC——
1527Element Genomics, Inc.—$4.8M
1528StabiLux Biosciences, Inc—$554K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Bruce CassidyDirector
  • Brian CogleyDirector · Executive Officer
  • Tamara JovonovichDirector · Executive Officer · Promoter
  • Martin LewisDirector
  • Michael LewisPromoter
  • Robert LewisDirector · Executive Officer · Promoter
  • David MehalickPromoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.